Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer.
Chavez KJ, Garimella SV, Lipkowitz S. Chavez KJ, et al. Among authors: lipkowitz s. Breast Dis. 2010;32(1-2):35-48. doi: 10.3233/BD-2010-0307. Breast Dis. 2010. PMID: 21778573 Free PMC article. Review. No abstract available.
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.
Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Cancer Res. 1996 Sep 15;56(18):4236-43. Cancer Res. 1996. PMID: 8797598
Fas expression and function in normal and malignant breast cell lines.
Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Cancer Res. 1996 Oct 15;56(20):4791-8. Cancer Res. 1996. PMID: 8841000
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Cancer Res. 1999 Feb 1;59(3):734-41. Cancer Res. 1999. PMID: 9973225
Glutathione-S-transferase (GST)-TRAIL extracellular domain fusion proteins were produced to analyze TRAIL-induced apoptosis. ...
Glutathione-S-transferase (GST)-TRAIL extracellular domain fusion proteins were produced to analyze TRAIL-induced apoptosis. ...
cbl-b inhibits epidermal growth factor receptor signaling.
Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S. Ettenberg SA, et al. Among authors: lipkowitz s. Oncogene. 1999 Mar 11;18(10):1855-66. doi: 10.1038/sj.onc.1202499. Oncogene. 1999. PMID: 10086340
cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
Ettenberg SA, Rubinstein YR, Banerjee P, Nau MM, Keane MM, Lipkowitz S. Ettenberg SA, et al. Among authors: lipkowitz s. Mol Cell Biol Res Commun. 1999 Aug;2(2):111-8. doi: 10.1006/mcbr.1999.0157. Mol Cell Biol Res Commun. 1999. PMID: 10542134
Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines.
Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Banerjee P, Nau MM, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Breast Cancer Res Treat. 2000 Nov;64(2):211-9. doi: 10.1023/a:1006458407515. Breast Cancer Res Treat. 2000. PMID: 11194457
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M, Ettenberg SA, Nau MM, Lipkowitz S. Cuello M, et al. Among authors: lipkowitz s. Gynecol Oncol. 2001 Jun;81(3):380-90. doi: 10.1006/gyno.2001.6194. Gynecol Oncol. 2001. PMID: 11371126
Statistical comparison of means was performed using Student's t test. RESULTS: The majority of the chemoresistant cells were also resistant to TRAIL alone. ...
Statistical comparison of means was performed using Student's t test. RESULTS: The majority of the chemoresistant cells were also res …
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, Dennis PA, Lipkowitz S. Cuello M, et al. Among authors: lipkowitz s. Cancer Res. 2001 Jun 15;61(12):4892-900. Cancer Res. 2001. PMID: 11406568
Biomarker assays in nipple aspirate fluid.
Klein P, Glaser E, Grogan L, Keane M, Lipkowitz S, Soballe P, Brooks L, Jenkins J, Steinberg SM, DeMarini DM, Kirsch I. Klein P, et al. Among authors: lipkowitz s. Breast J. 2001 Nov-Dec;7(6):378-87. doi: 10.1046/j.1524-4741.2001.07601.x. Breast J. 2001. PMID: 11843848
103 results
Jump to page
Feedback